In recent years, due to the combination of technological advances in the fields ofmeasurement instrumentation, communications, home-health care and textile-technology thedevelopment of medical devices has shifted towards applications of personal healthcare.There are well known the available solutions for heart rate monitoring successfully providedby Polar and Numetrex. Furthermore new monitoring applications are also investigated. Amongthese non-invasive monitoring applications, it is possible to find several ones enable bymeasurements of Electrical Bioimpedance.Analog Devices has developed the AD5933 Impedance Network Analyzer which facilitatesto a large extent the design and implementation of Electrical Bioimpedance Spectrometers in amuch reduced space. Such small size allows the development of a fully wearable bioimpedancemeasurement.With the development of a Electrical Bioimpedance-enable wearable medical device in focusfor personal healthcare monitoring, in this project, the issue of power management has beentargeted and a battery-driven Electrical Bioimpedance Spectrometer based in the AD5933 hasbeen implemented. The resulting system has the possibility to operate with a Li-Po battery with apower autonomy over 17 hours.

The value of heart rate variability (HRV) in the fields of health, disease, and exercise science has been established through numerous investigations. The typical mobile-based HRV device simply records interbeat intervals, without differentiation between noise or arrythmia as can be done with an electrocardiogram (ECG). The intent of this report is to validate a new single channel ECG device, the Movesense Medical sensor, against a conventional 12 channel ECG. A heterogeneous group of 21 participants performed an incremental cycling ramp to failure with measurements of HRV, before (PRE), during (EX), and after (POST). Results showed excellent correlations between devices for linear indexes with Pearson’s r between 0.98 to 1.0 for meanRR, SDNN, RMSSD, and 0.95 to 0.97 for the non-linear index DFA a1 during PRE, EX, and POST. There was no significant difference in device specific meanRR during PRE and POST. Bland–Altman analysis showed high agreement between devices (PRE and POST: meanRR bias of 0.0 and 0.4 ms, LOA of 1.9 to −1.8 ms and 2.3 to −1.5; EX: meanRR bias of 11.2 to 6.0 ms; LOA of 29.8 to −7.4 ms during low intensity exercise and 8.5 to 3.5 ms during high intensity exercise). The Movesense Medical device can be used in lieu of a reference ECG for the calculation of HRV with the potential to differentiate noise from atrial fibrillation and represents a significant advance in both a HR and HRV recording device in a chest belt form factor for lab-based or remote field-application.